Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains. - Wikidata - awgldk - TriplyDB

Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains.

Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains.

http://www.wikidata.org/entity/Q39609617

about

Small molecule inhibitors of a glycoside hydrolase attenuate inducible AmpC-mediated beta-lactam resistance Effective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin B Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains.In vivo functional and molecular characterization of the Penicillin-Binding Protein 4 (DacB) of Pseudomonas aeruginosa.Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein.Activity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strains Structural changes and differentially expressed genes in Pseudomonas aeruginosa exposed to meropenem-ciprofloxacin combination.The sentinel role of peptidoglycan recycling in the β-lactam resistance of the Gram-negative Enterobacteriaceae and Pseudomonas aeruginosa.An rhs gene of Pseudomonas aeruginosa encodes a virulence protein that activates the inflammasome.Structural and functional characterization of Pseudomonas aeruginosa global regulator AmpR.Distinct roles of major peptidoglycan recycling enzymes in β-Lactamase production in Shewanella oneidensis Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates AmpG inactivation restores susceptibility of pan-beta-lactam-resistant Pseudomonas aeruginosa clinical strains.Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.The β-lactamase gene regulator AmpR is a tetramer that recognizes and binds the D-Ala-D-Ala motif of its repressor UDP-N-acetylmuramic acid (MurNAc)-pentapeptide Sublethal concentrations of carbapenems alter cell morphology and genomic expression of Klebsiella pneumoniae biofilms Pseudomonas aeruginosa: resistance to the max Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.Mechanisms of antimicrobial resistance in Gram-negative bacilli.Development of resistance in wild-type and hypermutable Pseudomonas aeruginosa strains exposed to clinical pharmacokinetic profiles of meropenem and ceftazidime simulated in vitro.Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities.Cell Wall Recycling-Linked Coregulation of AmpC and PenB β-Lactamases through ampD Mutations in Burkholderia cenocepacia.Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.Identification of MupP as a New Peptidoglycan Recycling Factor and Antibiotic Resistance Determinant in Pseudomonas aeruginosa.Characterization of a Carbapenem-Hydrolyzing Enzyme, PoxB, in Pseudomonas aeruginosa PAO1.How bacteria consume their own exoskeletons (turnover and recycling of cell wall peptidoglycan)Nosocomial outbreak of a non-cefepime-susceptible ceftazidime-susceptible Pseudomonas aeruginosa strain overexpressing MexXY-OprM and producing an integron-borne PSE-1 betta-lactamase.AmpC beta-lactamases.Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence.Providing β-lactams a helping hand: targeting the AmpC β-lactamase induction pathway.Bacterial cell-wall recycling.PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa.Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth.Pharmacokinetics and pharmacodynamics in antibiotic dose optimization.Impact of AmpC Derepression on Fitness and Virulence: the Mechanism or the Pathway?Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections.Updates in the Management of Cephalosporin-Resistant Gram-Negative Bacteria.The extended-spectrum AmpC genotype of Pseudomonas aeruginosa strains from Egypt: an underlying threat to anti-pseudomonal treatment options.

P2860

Q27644480-A2E967EA-B444-402E-84F7-58A19F887DA6 Q28478261-5CFA4096-B964-4D13-AFF0-1E2B40E78503 Q30278439-C7E3C94B-A2A9-417B-A7AA-81E8F80EE138 Q30819461-E197C444-72ED-4FD8-B016-9193F456A72B Q33422951-F81C9D52-0643-4882-A803-B558DA4C969D Q33613660-5634F922-6244-401A-BF45-917D7D161B3B Q33798601-E1B6D8E9-94F7-43E6-8624-03F3D2FB268E Q34167642-1A1CE950-D0A4-4FDA-AEEB-067869F97B32 Q34246078-79F89586-9683-4204-A5BC-F039F081FEF2 Q34593307-771BE007-32C9-4D77-BA5C-B52916AC9D60 Q34596697-B0DEE4D9-B3EE-4211-9DAF-78E03DC60385 Q34648729-987E7D89-31BE-486D-B060-9C538065A246 Q34933120-60AE2AFF-EEA1-48DB-A8AA-CBF68ABF2136 Q35007624-793A02F7-FF7F-4CF9-950B-EAA70B69DCD5 Q35048806-FC00E18B-4AB1-47C2-8BB8-9B033E83B3E2 Q35076815-C306308D-0E90-4231-9ED0-BDBB9E574C48 Q35084559-0F51123A-139A-4478-9468-ABFBB84AF32C Q35879111-D43F2338-4E84-48D1-B5D8-CF262D1CB705 Q35935319-2AFE6D12-AC4E-48D0-B1D1-9C06A5F468D0 Q36095041-C578D506-FFCB-4A48-A39D-8D4409A86F8E Q36172484-F82C884F-724E-41D1-89F1-C8D93B0B5053 Q36290729-44366B0F-9AA5-43BE-B926-F458691BB0E9 Q36295397-06A70284-0A7E-4A25-8080-7705A5CBC8DF Q36313186-29B2C286-B5FC-4F2D-9C64-885622E5CC2F Q36326129-4949F14B-76E6-4898-84F6-30B8D02BB463 Q36571851-5089E179-B67D-406B-A1B7-0117C0FF72D9 Q37183911-76D1C73A-ED75-45C2-864E-2A2EAAEB8AEB Q37302114-9B0A9092-3C63-4ED5-A479-F08EC7ED4762 Q37366249-7C9C04E9-2322-47F8-B55E-7DBC8C97C07A Q37643058-BB8360CC-9F97-4070-BA31-5F029539DD45 Q37961906-F6A317D2-EF58-4BDB-992F-45466C4B64A8 Q38060821-51910244-994B-4537-9148-B26AA6C45788 Q38309969-5F140237-DBAD-4929-9405-6AAA5167C0FA Q38599969-90B066E2-0045-4EB7-8099-15F6F97D6EF7 Q38626934-512B2651-FB34-4F28-9D7C-8719351B360C Q38664871-F78B30C5-53BC-4D87-A922-A62260A5A56C Q38802410-6F371116-44EF-491D-AA61-319BE0A1FB00 Q38856197-64C101FF-9FE7-4BEF-BA51-CD94641AA2FB Q38981397-B8A3E93D-2EAD-41C3-A1F5-375EE4852736 Q38988534-321516C7-E587-48E8-A01A-E12AFD6791FB

P2860

Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains.

http://www.wikidata.org/entity/Q39609617

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Molecular mechanisms of beta-l ...... s aeruginosa clinical strains.

@en

Molecular mechanisms of beta-l ...... s aeruginosa clinical strains.

@nl

type

label

Molecular mechanisms of beta-l ...... s aeruginosa clinical strains.

@en

Molecular mechanisms of beta-l ...... s aeruginosa clinical strains.

@nl

prefLabel

Molecular mechanisms of beta-l ...... s aeruginosa clinical strains.

@en

Molecular mechanisms of beta-l ...... s aeruginosa clinical strains.

@nl

P1433

Q39609617-40443DD2-D31B-46B0-84FF-C22F081CD593

P1476

Q39609617-FEFC68E4-FE16-4E12-BA14-9112AB94DEFA

P2093

Q39609617-95D4AFC9-4559-4D65-A6F5-EAAF558FABDD

Q39609617-AD8B466A-B56A-40FD-A8B9-7FDFFBBDE235

Q39609617-D6D761E9-440F-4440-9BB1-FEA50852A7C0

Q39609617-DEDB27BD-6C03-4939-86B1-41C610F2E32B

P2860

Q39609617-00297C13-61D7-47CA-8577-7EFE06F2B0A0

Q39609617-05D68A45-FED3-45A6-887E-D54E9C5006C3

Q39609617-0724C706-F0F3-4D53-BE7E-3E8F734E1C42

Q39609617-0ABA0239-2681-424C-8433-B986FFABF3E4

Q39609617-0F4CF925-A53F-4C46-9B50-F4433113E479

Q39609617-10E3EFC6-3D60-4FB8-A8A4-DA28A4DFFC01

Q39609617-1DB82D66-444B-4CCF-B5EC-67C9313ACFEF

Q39609617-2B111734-FEE9-4E6C-A718-98C26A065CFD

Q39609617-2F0E0FE5-3B4C-490A-9C3B-BC799A8ABBF1

Q39609617-37E4ACD0-69B4-419E-8259-73136C652FA0

P304

Q39609617-C1179411-CF59-4925-8519-63233A6E2EFD

P31

Q39609617-470EE7C9-BB46-4327-88A0-AC38F64D9900

P356

Q39609617-8BF8916B-2B7D-423D-A17D-7C90286D6E7D

P407

Q39609617-D16C4A6E-E03F-4766-9DC9-20B79D899BAF

P433

Q39609617-287DC661-A86D-45F0-B193-5590944D7A30

P478

Q39609617-602205C9-E4D5-4010-99DC-D24160D58C4C

P50

Q39609617-49626D75-3240-44A1-AA27-0078AA3AA194

Q39609617-9719116E-053C-4AD4-AD4C-E368ABEEB757

P577

Q39609617-91348643-4399-4A44-84F7-1C88C4296580

P5875

Q39609617-7EAD9CFA-6147-4F53-BFC2-F8345F5D5A2B

P698

Q39609617-69646EE7-7C9D-41D1-83A0-F3E57EE3627C

P921

Q39609617-9DC617E7-6E66-47D0-920D-BC0798370C79

P932

Q39609617-3FC80043-2E4A-4C3F-B4EE-588E8E253CBD

P356

AAC.49.11.4733-4738.2005

P1433

Antimicrobial Agents and Chemotherapy

P1476

Molecular mechanisms of beta-l ...... as aeruginosa clinical strains

@en

P2093

Antonio Oliver

http://www.w3.org/2001/XMLSchema#string

Carmen Vidal

http://www.w3.org/2001/XMLSchema#string

José L Pérez

http://www.w3.org/2001/XMLSchema#string

Olivia Gutiérrez

http://www.w3.org/2001/XMLSchema#string

P2860

Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen

Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents

beta-Lactamases in laboratory and clinical resistance

A functional classification scheme for beta-lactamases and its correlation with molecular structure

Investigation of the Pseudomonas aeruginosa ampR gene and its role at the chromosomal ampC beta-lactamase promoter

An ampD gene in Pseudomonas aeruginosa encodes a negative regulator of AmpC beta-lactamase expression.

Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia

Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa

Lung infections associated with cystic fibrosis.

Evaluation of the Wider system, a new computer-assisted image-processing device for bacterial identification and susceptibility testing.

P304

4733-4738

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.49.11.4733-4738.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

María D Maciá

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7515974

http://www.w3.org/2001/XMLSchema#string

P698

16251318

http://www.w3.org/2001/XMLSchema#string

P921

Pseudomonas aeruginosa

P932

1280133

http://www.w3.org/2001/XMLSchema#string